Loading...
Loading...
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc.. Spoken Alpha tracks ALDX's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks ALDX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.75 | $3.02 | -9.1% | +5.2% | +5.4% |
| Q4 FY2026 | $2.72 | $3.20 | -15.0% | +0.7% | +0.5% |
| Q3 FY2026 | $2.44 | $3.09 | -21.1% | -2.2% | -0.8% |
| Q2 FY2026 | $2.74 | $3.02 | -9.2% | -1.1% | -2.4% |
| Q1 FY2025 | $2.37 | $3.01 | -21.3% | -2.0% | -4.4% |
| Q4 FY2025 | $2.57 | $3.07 | -16.4% | +3.8% | +5.0% |
| Q3 FY2025 | $2.72 | $3.13 | -13.0% | +2.9% | +2.9% |
| Q2 FY2025 | $2.44 | $3.12 | -21.9% | -3.8% | -4.1% |
| Q1 FY2024 | $2.60 | $3.16 | -17.7% | +0.1% | +0.6% |
| Q4 FY2024 | $2.69 | $3.31 | -18.7% | +0.8% | -2.1% |
Spoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
CEO since 2023 • 10/12 beats (83%) • guidance suspended Q1 FY2026
OTHER_C_SUITE since 2024 • 5/8 beats (63%) • last guidance raise Q2 FY2026
OTHER since 2024 • 3/8 beats (38%) • last guidance cut Q2 FY2026
OTHER since 2024 • 4/8 beats (50%) • guidance suspended Q2 FY2026
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ALDX.
curl https://api.spokenalpha.com/v1/companies/ALDX